Skip to content

The Potential of Do-it-yourself Devices for Obtaining Personal Health Data

The Potential of Do-it-yourself Devices for Obtaining Personal Health Data - P4@TNO Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02166684
Acronym
P4@TNO
Enrollment
33
Registered
2014-06-18
Start date
2014-09-30
Completion date
2014-12-31
Last updated
2014-12-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Behaviour Change, Self-monitoring of Health

Keywords

Do-it-yourself devices, User-experiences, Health behavior, Self-measurement, Methodology, Evaluation, Personal health records, Blood Glucose Self-Monitoring, Self Blood Pressure Monitoring

Brief summary

The study aims to evaluate whether do-it-yourself devices for self-measuring health parameters by subjects can be used for obtaining useful data in scientific studies. Besides, the study aims to evaluate if increased awareness of own health status by self-monitoring health parameters also serves as motivational instrument for changing health behaviour.

Detailed description

During this three month study subjects will self-monitor multiple parameters of health with do-it-yourself devices. Subjects are supplied with devices for measuring physical activity, food intake, body weight, blood pressure, blood glucose level and blood cholesterol level. These devices have to be used with varying frequencies, ranging from continuously to only a baseline- and endpoint measure. Subjects will have to upload data resulting from these self-measures to an encoded account on an online portal. At any time during the study, subjects can log-on to this portal, to gain insight in their own health parameters. Only encoded subject data can be exported from this portal for data analysis.

Interventions

DEVICEDo-it-yourself devices

Medisana Vifit is worn every day all-day by each subject Subjects use Medisana MTX Blood pressure monitor twice per week for 13 weeks to measure their blood pressure. Blood cholesterol is measured by subjects using the Mission Cholesterol 3-1 meter once at baseline and once after 13 weeks Subjects use Medisana BS 440 BT scale daily In three weeks (week 1, week 7 and week 13) subjects self-record food intake at three days (two week days and on weekend day) using the FatSecret app. Subjects self-measure fasting blood glucose twice per week for 13 weeks. Subjects perform a do-it-yourself Oral Glucose Tolerance Test in week 1 and week 13. Subjects use the Medisana MediTouch 2 for assessing blood glucose levels at t=0, t=30, t=60, t=90 and t=120.

Sponsors

W.J. Pasman
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 67 Years
Healthy volunteers
Yes

Inclusion criteria

1. Age ranging from 18 - 67 years 2. Desk-job and not exceed the Dutch Standard of Healthy Physical Activity of 5 hours/week 3. Healthy as assessed by the Health and Lifestyle questionnaire 4. Body mass index: 20 - 30 kg/m2 5. Able to use self-monitoring devices 6. Voluntary participation 7. Having given written informed consent 8. Willing to comply with study procedures 9. Willingness to share pseudonymised data on food intake with external party Fatsecret (food intake app provider) 10. Willingness to share pseudonymised data on blood glucose, blood pressure, physical activity and body weight with external party Medisana (provider of measurement Toolkit) 11. Willingness to share pseudonymised data on food intake, blood glucose, blood cholesterol, blood pressure, physical activity and body weight with the Nutrition Research Cohort (NRC) database 12. Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data by TNO 13. Have a desktop or laptop with internet access at home 14. Subjects should own a Smartphone with Bluetooth that runs either a recent version of iOS or Android. 15. Having one of the TNO locations in Delft, Den Haag or Rijswijk as posting

Exclusion criteria

1. Use of concomitant medication including medication known for its effects on blood glucose, cholesterol or insulin 2. Having a history of medical or surgical events that may significantly affect the study outcome, including physical limitations or cardio-vascular events 3. Having a pacemaker 4. Currently suffering from diabetes type I or type II as determined by the general practitioner 5. Reported slimming or medically prescribed diet 6. Physical, mental or practical limitations in using computerized systems 7. Alcohol consumption \> 28 units/week for males and \> 21 units (drinks)/week for females 8. Reported unexplained weight loss or gain of \> 2 kg in the three months prior to the pre-study screening 9. Partner or first or second-degree relative from TNO personnel stationed at a TNO location in Zeist, Leiden, Hoofddorp or Soesterberg where the study protocol was developed.

Design outcomes

Primary

MeasureTime frameDescription
Percentage of complete datasetsend of study (after 13 weeks)percentage is calculated for total complete datasets as well as complete datasets per device
Health behaviour changebaseline and after 13 weeks (end of study)established by comparing baseline values for food intake and physical activity as measured by a Lifestyle-questionnaire
User-experiences with do-it-yourself devicesafter 13 weeks (end of study)as measured by a questionnaire on user-experiences as well as focus group interviews for more in-depth information

Secondary

MeasureTime frameDescription
Fasting blood glucose leveltwice per week at baseline and from week 1 until 13self-assessed after overnight fast (at least eight hours)
body weightthree times per week at baseline and from week 1 to 13self-assessed with a smart scale that also calculates BMI and body fat percentage
blood cholesterol levelsbaseline and after 13 weeks (end of study)self-assessed
self-measured blood pressurebaseline + weekly from week 1 until week 13
change in vitality as assessed with a vitality questionnaire (Vita-16)baseline and week 13
change in subjective stress level as assessed with DASS-21 questionnairebaseline and week 13
change in subjective quality of life as assessed with RAND-36 questionnairebaseline and week 13
oral glucose tolerance test (OGTT)week 1 and week 13do-it-yourself version of OGTT; blood glucose levels will be assessed using the Medisana MediTouch 2
self-recorded food intakeweek 1, week 7 and week 13every of the three periods, food intake will be recorded at two week days and one weekend day
daily physical activitydaily during 13 weeks (baseline - end of study)wearable activity tracker that measures number of steps taken, duration of activity and estimates the number of calories burned

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026